ArticleBlood advances2024

Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B.

Doris Quon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.